...
首页> 外文期刊>Glycobiology. >Chemo-enzymatic synthesis of lipid-linked GlcNAc(2)Man(5) oligosaccharides using recombinant Alg1, Alg2 and Alg11 proteins
【24h】

Chemo-enzymatic synthesis of lipid-linked GlcNAc(2)Man(5) oligosaccharides using recombinant Alg1, Alg2 and Alg11 proteins

机译:使用重组ALG1,ALG2和ALG11蛋白的脂质连接GLCNAC(2)人(5)人(5)寡糖的化学酶合成

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The biosynthesis of eukaryotic lipid-linked oligosaccharides (LLOs) that act as donor substrates in eukaryotic protein N-glycosylation starts on the cytoplasmic side of the endoplasmic reticulum and includes the sequential addition of five mannose units to dolichol-pyrophosphate-GlcNAc(2). These reactions are catalyzed by the Alg1, Alg2 and Alg11 gene products and yield Dol-PP-GlcNAc(2)Man(5), an LLO intermediate that is subsequently flipped to the lumen of the endoplasmic reticulum. While the purification of active Alg1 has previously been described, Alg11 and Alg2 have been mostly studied in vivo. We here describe the expression and purification of functional, full length Alg2 protein. Along with the purified soluble domains Alg1 and Alg11, we used Alg2 to chemo-enzymatically generate Dol-PP-GlcNAc(2)Man(5) analogs starting from synthetic LLOs containing a chitobiose moiety coupled to oligoprenyl carriers of distinct lengths (C-10, C-15, C-20 and C-25). We found that while the addition of the first mannose unit by Alg1 was successful with all of the LLO molecules, the Alg2-catalyzed reaction was only efficient if the acceptor LLOs contained a sufficiently long lipid tail of four or five isoprenyl units (C-20 and C-25). Following conversion with Alg11, the resulting C-20 or C-25 -containing GlcNAc(2)Man(5) LLO analogs were successfully used as donor substrates of purified single-subunit oligosaccharyltransferase STT3A from Trypanosoma brucei. Our results provide a chemo-enzymatic method for the generation of eukaryotic LLO analogs and are the basis of subsequent mechanistic studies of the enigmatic Alg2 reaction mechanism.
机译:作为真核蛋白质N-糖基化中的真核脂质连接的低聚糖(LLOS)的生物合成,其在内质网的细胞质侧开始,并且包括将5个甘露糖单位的连续添加到多氯焦磷酸盐-GlcNAc(2)中。这些反应由ALG1,ALG2和ALG11基因产物催化,产量DOL-PP-GLCNAC(2)人(5),将随后翻转到内质网的内腔的LLO中间体。虽然先前已经描述了活性ALG1的纯化,但是在体内已经研究了ALG11和ALG2。我们在此描述功能性全长ALG2蛋白的表达和纯化。与纯化的可溶性结构域ALG1和ALG11一起,我们使用从含有不同长度的寡糖基载体的氯化银部分(C-10 ,C-15,C-20和C-25)。我们发现通过所有LLO分子加入ALG1的甘露糖单位,如果受体LLO含有足够长的四个异戊二烯基单位的脂质尾(C-20和c-25)。随着ALG11的转化后,得到的C-20或C-25 - 甲型-250或C-25 - 甲型(5)LLO类似物成功用作来自胰蛋白酶瘤Brucei的纯化的单亚基寡核苷酸转移酶STT3a的供体底物。我们的研究结果为生成真核LLO类似物提供了一种化学酶法,是后续藻类反应机制的后续机械研究的基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号